AstraZeneca lung and breast cancer data at WCLC and ESMO.
The Pharma Data
SEPTEMBER 2, 2021
Transforming treatment of advanced cancers with antibody drug conjugates (ADCs). Changing treatment paradigms with industry-leading PARP inhibitors and next-wave DNA damage response therapies. Durvalumab ± Tremelimumab + Platinum-Etoposide in 1L ES-SCLC: Exploratory Analysis of HLA Genotype and Survival in CASPIAN. Lead author.
52 
Let's personalize your content